As per the research conducted by KD Market research, the
report titled “ Endometrial Ablation Devices
Market ”
provides current as well as future analysis of the market by evaluating the
major applications, advantages, trends, and challenges. The report dives deeper
to produce useful insights into Endometrial Ablation Devices Market such as major global regions and key
competitors and strategies that can be used for the entry-level player too.
Endometrial ablation is adopted to remove or destroy the
endometrial lining of the uterus for the treatment of heavy menstrual bleeding.
Women with heavy menstrual bleeding are prescribed medicines. However,
endometrial ablation is performed in case medication fails. This procedure is
not recommended for women who wish to conceive.
Request for sample@ https://www.kdmarketresearch.com/sample/3187
The endometrial ablation devices market is expected
to grow at a significant rate during the forecast period, owing to increase in
awareness regarding endometrial ablation technology, increase in prevalence of
menorrhagia, and rise in preference for endometrial ablation over the
hysterotomy. In addition, technological advancements in endometrial ablation
devices and benefits of the endometrial ablation over the surgical procedures
further facilitate the growth of the market. However, stringent government
regulations for the approval of endometrial ablation devices and risks
associated with the use of these devices are expected to impede the market
growth. The endometrial ablation devices market generated $882 million
in 2017, and is projected to reach $1,299 million by 2024, growing at a CAGR of
5.6% from 2018 to 2024.
The global endometrial ablation devices market is
segmented based on technology type, end user, and region. Based on technology
type, the market is classified into radiofrequency ablation, cryoablation,
hydrothermal ablation, thermal balloon, hysteroscopic ablation, and others.
According to end user, the market is divided into ambulatory surgery center,
clinic, and hospitals. Based on region, the market is studied across North
America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain,
and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea,
and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and
rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along
with current trends and future estimations to elucidate the imminent investment
pockets.
It offers a quantitative analysis from 2017 to 2024, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Technology Type
-Radiofrequency Ablation
-Cryoablation
-Hydrothermal Ablation
-Thermal Balloon
-Hysteroscopic Ablation
-Others
-Cryoablation
-Hydrothermal Ablation
-Thermal Balloon
-Hysteroscopic Ablation
-Others
By End User
-Ambulatory Surgery Center
-Clinic
-Hospital
-Clinic
-Hospital
By Region
-North America
-U.S.
-Canada
-Mexico
-Europe
-Germany
-France
-UK
-Italy
-Spain
-Rest of Europe
-Asia-Pacific
-Japan
-China
-Australia
India
-South Korea
-Rest of Asia-Pacific
-LAMEA
-Brazil
-Saudi Arabia
-South Africa
-Rest of LAMEA
-U.S.
-Canada
-Mexico
-Europe
-Germany
-France
-UK
-Italy
-Spain
-Rest of Europe
-Asia-Pacific
-Japan
-China
-Australia
India
-South Korea
-Rest of Asia-Pacific
-LAMEA
-Brazil
-Saudi Arabia
-South Africa
-Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
-AEGEA Medical, Inc.
-Boston Scientific Corporation
-CooperSurgical Inc.
-Hologic, Inc.
-Idoman Teoranta
-Minerva Surgical, Inc.
-Olympus Corporation
-Omnitech Systems, Inc.
-Smith & Nephew plc. (Medtronic plc.)
-Veldana Medical SA
-Boston Scientific Corporation
-CooperSurgical Inc.
-Hologic, Inc.
-Idoman Teoranta
-Minerva Surgical, Inc.
-Olympus Corporation
-Omnitech Systems, Inc.
-Smith & Nephew plc. (Medtronic plc.)
-Veldana Medical SA
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players
are not profiled in the report. The same will be included on request.)
-Karl Storz GmbH & Co. KG
-Richard Wolf GmbH
-AngioDynamics Inc.
-Microsulis Americas, Inc.
-Richard Wolf GmbH
-AngioDynamics Inc.
-Microsulis Americas, Inc.
Browse full report with toc@ https://www.kdmarketresearch.com/report/3187/endometrial-ablation-devices-market-amr
Table of content
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Market Share Analysis
3.2.2. Market Share Analysis
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Benefits of endometrial ablation over hysterectomy
3.3.1.2. Advancement in endometrial ablation techniques
3.3.1.3. High number of menorrhagia affected population
3.3.1.4. Increase in healthcare expenditures worldwide
3.3.1.2. Advancement in endometrial ablation techniques
3.3.1.3. High number of menorrhagia affected population
3.3.1.4. Increase in healthcare expenditures worldwide
3.3.2. Restraint
3.3.2.1. Risk associated with endometrial ablation
3.3.3. Opportunities
3.3.3.1. Growth opportunities in emerging markets
3.3.3.2. Increase in demand for minimally invasive procedures
3.3.3.2. Increase in demand for minimally invasive procedures
3.3.4. Impact Analyses
CHAPTER 4: ENDOMETRIAL ABLATION DEVICES MARKET, BY
TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Radiofrequency Ablation
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Cryoablation
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Hydrothermal Ablation
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Thermal Balloon
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.5.3. Market analysis, by country
4.6. Hysteroscopic Ablation
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Others
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
CHAPTER 5: ENDOMETRIAL ABLATION DEVICES MARKET, BY END
USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Ambulatory Surgical Center
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.2.2. Market analysis, by country
5.3. Clinics
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.3.2. Market analysis, by country
5.4. Hospitals
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.4.2. Market analysis, by country
CHAPTER 6: ENDOMETRIAL ABLATION DEVICES MARKET BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. endometrial ablation devices market, by
technology type
6.2.2.1.2. U.S. endometrial ablation devices market, by end user
6.2.2.1.2. U.S. endometrial ablation devices market, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada endometrial ablation devices market, by
technology type
6.2.2.2.2. Canada endometrial ablation devices market, by end user
6.2.2.2.2. Canada endometrial ablation devices market, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico endometrial ablation devices market, by
technology type
6.2.2.3.2. Mexico endometrial ablation devices market, by end user
6.2.2.3.2. Mexico endometrial ablation devices market, by end user
6.2.3. North America endometrial ablation devices market,
by technology type
6.2.4. North America endometrial ablation devices market, by end user
6.2.4. North America endometrial ablation devices market, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany endometrial ablation devices market, by
technology type
6.3.2.1.2. Germany endometrial ablation devices market, by end user
6.3.2.2. France
6.3.2.2.1. France endometrial ablation devices market, by
technology type
6.3.2.2.2. France endometrial ablation devices market, by end user
6.3.2.2.2. France endometrial ablation devices market, by end user
6.3.2.3. UK
6.3.2.3.1. UK endometrial ablation devices market, by
technology type
6.3.2.3.2. UK endometrial ablation devices market, by end user
6.3.2.3.2. UK endometrial ablation devices market, by end user
6.3.2.4. Italy
6.3.2.4.1. Italy endometrial ablation devices market, by
technology type
6.3.2.4.2. Italy endometrial ablation devices market, by end user
6.3.2.4.2. Italy endometrial ablation devices market, by end user
6.3.2.5. Spain
6.3.2.5.1. Spain endometrial ablation devices market, by
technology type
6.3.2.5.2. Spain endometrial ablation devices market, by end user
6.3.2.5.2. Spain endometrial ablation devices market, by end user
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe endometrial ablation devices
market, by technology type
6.3.2.6.2. Rest of Europe endometrial ablation devices market, by end user
6.3.2.6.2. Rest of Europe endometrial ablation devices market, by end user
6.3.3. Europe endometrial ablation devices market, by
technology type
6.3.4. Europe endometrial ablation devices market, by end user
6.3.4. Europe endometrial ablation devices market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan endometrial ablation devices market, by
technology type
6.4.2.1.2. Japan endometrial ablation devices market, by end user
6.4.2.1.2. Japan endometrial ablation devices market, by end user
6.4.2.2. China
6.4.2.2.1. China endometrial ablation devices market, by
technology type
6.4.2.2.2. China endometrial ablation devices market, by end user
6.4.2.2.2. China endometrial ablation devices market, by end user
6.4.2.3. Australia
6.4.2.3.1. Australia endometrial ablation devices market, by
technology type
6.4.2.3.2. Australia endometrial ablation devices market, by end user
6.4.2.3.2. Australia endometrial ablation devices market, by end user
6.4.2.4. India
6.4.2.4.1. India endometrial ablation devices market, by
technology type
6.4.2.4.2. India endometrial ablation devices market, by end user
6.4.2.4.2. India endometrial ablation devices market, by end user
6.4.2.5. South Korea
6.4.2.5.1. South Korea endometrial ablation devices market,
by technology type
6.4.2.5.2. South Korea endometrial ablation devices market, by end user
6.4.2.5.2. South Korea endometrial ablation devices market, by end user
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific endometrial ablation devices
market, by technology type
6.4.2.6.2. Rest of Asia-Pacific endometrial ablation devices market, by end user
6.4.2.6.2. Rest of Asia-Pacific endometrial ablation devices market, by end user
6.4.3. Asia-Pacific endometrial ablation devices market,
by technology type
6.4.4. Asia-Pacific endometrial ablation devices market, by end user
6.4.4. Asia-Pacific endometrial ablation devices market, by end user
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil endometrial ablation devices market, by
technology type
6.5.2.1.2. Brazil endometrial ablation devices market, by end user
6.5.2.1.2. Brazil endometrial ablation devices market, by end user
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia endometrial ablation devices market,
by technology type
6.5.2.2.2. Saudi Arabia endometrial ablation devices market, by end user
6.5.2.2.2. Saudi Arabia endometrial ablation devices market, by end user
6.5.2.3. South Africa
6.5.2.3.1. South Africa endometrial ablation devices market,
by technology type
6.5.2.3.2. South Africa endometrial ablation devices market, by end user
6.5.2.3.2. South Africa endometrial ablation devices market, by end user
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA endometrial ablation devices
market, by technology type
6.5.2.4.2. Rest of LAMEA endometrial ablation devices market, by end user
6.5.2.4.2. Rest of LAMEA endometrial ablation devices market, by end user
6.5.3. LAMEA endometrial ablation devices market, by
technology type
6.5.4. LAMEA endometrial ablation devices market, by end user
6.5.4. LAMEA endometrial ablation devices market, by end user
CHAPTER 7: COMPANY PROFILES
7.1. AEGEA Medical, Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Product portfolio
7.1.4. Key strategic moves and developments
7.1.2. Company snapshot
7.1.3. Product portfolio
7.1.4. Key strategic moves and developments
7.2. Boston Scientific Corporation
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. Hologic, Inc.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Idoman Teoranta
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Product portfolio
7.4.2. Company snapshot
7.4.3. Product portfolio
7.5. Medtronic Plc. (Smith & Nephew Plc.)
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Minerva Surgical, Inc.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product portfolio
7.6.4. Key strategic moves and developments
7.6.2. Company snapshot
7.6.3. Product portfolio
7.6.4. Key strategic moves and developments
7.7. Olympus Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Omnitech Systems, Inc.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.9. The Cooper Companies, Inc. (CooperSurgical, Inc.)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Veldana Medical SA
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. product portfolio
7.10.2. Company snapshot
7.10.3. product portfolio
TABLE 01. GLOBAL ENDOMETRIAL ABLATION MARKET, BY TECHNOLOGY
TYPE, 20172024 ($MILLION)
TABLE 02. RADIOFREQUENCY ABLATION MARKET, BY REGION, 20172024 ($MILLION)
TABLE 03. CRYOABLATION MARKET, BY REGION, 20172024 ($MILLION)
TABLE 04. HYDROTHERMAL ABLATION MARKET, BY REGION, 20172024 ($MILLION)
TABLE 05. THERMAL BALLOON MARKET, BY REGION, 20172024 ($MILLION)
TABLE 06. HYSTEROSCOPIC ABLATION MARKET, BY REGION, 20172024 ($MILLION)
TABLE 07. OTHER ENDOMETRIAL ABLATION TECHNOLOGY MARKET, BY REGION, 20172024 ($MILLION)
TABLE 08. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER,
20172024
($MILLION)
TABLE 09. ENDOMETRIAL ABLATION DEVICES MARKET FOR AMBULATORY SURGICAL CENTER, BY REGION, 20172024 ($MILLION)
TABLE 10. ENDOMETRIAL ABLATION DEVICES MARKET FOR CLINIC, BY REGION, 20172024 ($MILLION)
TABLE 11. ENDOMETRIAL ABLATION DEVICES MARKET FOR HOSPITAL, BY REGION, 20172024 ($MILLION)
More….
Check for discount@ https://www.kdmarketresearch.com/discount/3187
About Us:
KD Market Research is one of the best market research
organization that provides B2B research on the growth opportunities of the
industry which is the prime factor of the overall revenue of the organization.
We identify the pain points which our client is facing around revenue methods
and provide them with a comprehensive database which helps them to make
intelligent decisions that could ensure growth to the organization.
Our Services include market intelligence, competitive
intelligence, and customized research. These research reports help the organizations
to make quick and powerful decisions that make out highest growth in revenue.
Contact
us - KD
Market Research
150 State Street, Albany,
New York, USA 12207
No comments:
Post a Comment